Issn Print: 0923-7534
Publication Date: 2017/10/01
Tumour- and class-specific patterns of immune-related adverse events of immune checkpoint inhibitors: a systematic review
L. Khoja; D. Day; T. Wei-Wu Chen; L. L. Siu; A. R. Hansen
Author Information: Clinical Development Unit, Early Clinical Development, AstraZeneca UK plc, Melbourn Science Park, Melbourn, Hertfordshire;
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.